BOLD
Price
$1.41
Change
+$0.02 (+1.44%)
Updated
Jun 12 closing price
Capitalization
31.67M
65 days until earnings call
Intraday BUY SELL Signals
CATX
Price
$2.95
Change
-$0.02 (-0.67%)
Updated
Jun 12 closing price
Capitalization
336.44M
66 days until earnings call
Intraday BUY SELL Signals
SNES
Price
$1.65
Change
-$0.04 (-2.37%)
Updated
Jun 12 closing price
Capitalization
8.75M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BOLD or CATX or SNES

Header iconBOLD vs CATX vs SNES Comparison
Open Charts BOLD vs CATX vs SNESBanner chart's image
BOLD vs CATX vs SNES Comparison Chart in %
loading
loading
loading
View a ticker or compare two or three
Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2026
Stock price -- (BOLD: $1.41CATX: $2.95SNES: $1.65)
Brand notoriety: BOLD, CATX and SNES are all not notable
BOLD represents the Biotechnology industry, CATX is part of the Medical/Nursing Services industry, and SNES is in the Chemicals: Specialty industry.
Current volume relative to the 65-day Moving Average: BOLD: 4%, CATX: 76%, SNES: 33%
Market capitalization -- BOLD: $31.67M, CATX: $336.44M, SNES: $8.75M
BOLD [@Biotechnology] is valued at $31.67M. CATX’s [@Medical/Nursing Services] market capitalization is $336.44M. SNES [@Chemicals: Specialty] has a market capitalization of $8.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $112.92B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $153.59B to $0. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $242.07B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.43B. The average market capitalization across the [@Medical/Nursing Services] industry is $12.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLD’s FA Score shows that 1 FA rating(s) are green whileCATX’s FA Score has 0 green FA rating(s), and SNES’s FA Score reflects 0 green FA rating(s).

  • BOLD’s FA Score: 1 green, 4 red.
  • CATX’s FA Score: 0 green, 5 red.
  • SNES’s FA Score: 0 green, 5 red.
According to our system of comparison, BOLD is a better buy in the long-term than SNES, which in turn is a better option than CATX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLD’s TA Score shows that 3 TA indicator(s) are bullish while CATX’s TA Score has 4 bullish TA indicator(s), and SNES’s TA Score reflects 4 bullish TA indicator(s).

  • BOLD’s TA Score: 3 bullish, 5 bearish.
  • CATX’s TA Score: 4 bullish, 3 bearish.
  • SNES’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CATX is a better buy in the short-term than BOLD and SNES.

Price Growth

BOLD (@Biotechnology) experienced а -0.70% price change this week, while CATX (@Medical/Nursing Services) price change was -2.64% , and SNES (@Chemicals: Specialty) price fluctuated +7.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.78%. For the same industry, the average monthly price growth was +90.18%, and the average quarterly price growth was +2050.65%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.39%. For the same industry, the average monthly price growth was +1.95%, and the average quarterly price growth was -16.80%.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was +3.29%. For the same industry, the average monthly price growth was +0.49%, and the average quarterly price growth was +20.85%.

Reported Earning Dates

BOLD is expected to report earnings on Aug 17, 2026.

CATX is expected to report earnings on Aug 18, 2026.

SNES is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+0.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical/Nursing Services (-1.39% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Chemicals: Specialty (+3.29% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CATX($336M) has a higher market cap than BOLD($31.7M) and SNES($8.75M). BOLD YTD gains are higher at: 17.500 vs. CATX (7.273) and SNES (-22.897). SNES has higher annual earnings (EBITDA): -6.63M vs. BOLD (-59.47M) and CATX (-108.44M). CATX has more cash in the bank: 271M vs. BOLD (92.8M) and SNES (6.8M). SNES has less debt than CATX and BOLD: SNES (2.63M) vs CATX (4.23M) and BOLD (48.3M). SNES has higher revenues than BOLD and CATX: SNES (2.23M) vs BOLD (0) and CATX (0).
BOLDCATXSNES
Capitalization31.7M336M8.75M
EBITDA-59.47M-108.44M-6.63M
Gain YTD17.5007.273-22.897
P/E Ratio0.16N/A0.02
Revenue002.23M
Total Cash92.8M271M6.8M
Total Debt48.3M4.23M2.63M
FUNDAMENTALS RATINGS
CATX vs SNES: Fundamental Ratings
CATX
SNES
OUTLOOK RATING
1..100
5572
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
6564
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5011

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNES's Valuation (60) in the Biotechnology industry is in the same range as CATX (89). This means that SNES’s stock grew similarly to CATX’s over the last 12 months.

SNES's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CATX (100). This means that SNES’s stock grew similarly to CATX’s over the last 12 months.

CATX's SMR Rating (98) in the Biotechnology industry is in the same range as SNES (99). This means that CATX’s stock grew similarly to SNES’s over the last 12 months.

SNES's Price Growth Rating (64) in the Biotechnology industry is in the same range as CATX (65). This means that SNES’s stock grew similarly to CATX’s over the last 12 months.

SNES's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CATX (100). This means that SNES’s stock grew similarly to CATX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BOLDCATXSNES
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 19 days ago
79%
Bullish Trend 5 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 6 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
Bearish Trend 6 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BOLD
Daily Signal:
Gain/Loss:
CATX
Daily Signal:
Gain/Loss:
SNES
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USPRX89.80N/A
N/A
Victory 500 Index Reward
IGMIX9.73N/A
N/A
Voya Global Insights Portfolio I
BRSSX16.39N/A
N/A
MFS Blended Research Small Cap Eq R2
HRLFX10.85N/A
N/A
Hartford Real Asset F
SWMCX16.15N/A
N/A
Schwab ® US Mid-Cap Index